Accessibility StatementSkip Navigation LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of LNTH during the class period listed are encouraged to contact the firm regarding possibl ...

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, d ...

公司诉讼事件 - iRobot公司因违反1934年证券交易法第10(b)条和第20(a)条及SEC规则10b-5被提起集体诉讼 [1] - 诉讼指控公司在2024年1月29日至2025年3月11日期间发布虚假和误导性声明 [2] - 公司被指未能如实披露与亚马逊合并协议终止后重组计划的实际影响 [2] 公司经营状况 - iRobot在亚马逊并购失败后未能保持独立实体的盈利能力 [2] - 公司公开声明在整个集体诉讼期间被认定为虚假且具有重大误导性 [2] 股东参与机制 - 在2025年9月5日前购入股票的股东可申请成为首席原告 [1][2] - 注册股东将获得案件生命周期内的投资组合监控服务 [3] - 参与诉讼无需支付任何成本或承担义务 [3]

集体诉讼事件 - 股东集体诉讼针对Alto Neuroscience公司 指控其在2024年2月2日至2024年10月22日期间发布重大虚假或误导性陈述[1][2] - 诉讼代表通过IPO文件购买公司普通股或在上述期间购买公司证券的所有投资者[1] 产品管线问题 - 公司主打产品ALTO-100在治疗重度抑郁症方面的疗效低于管理层向投资者传达的水平[2] - ALTO-100的临床、监管和商业前景被夸大 导致公司业务和财务前景被过度宣传[2] 诉讼程序安排 - 股东参与截止日期为2025年9月19日 主要原告申请截止日期相同[3] - 注册股东将获得案件生命周期内的状态更新 参与诉讼无需成本或义务[3]